SARS-CoV-2 seroprevalence and risk of asymptomatic infection in patients with inflammatory rheumatic diseases compared to the general population prior to COVID-19 vaccination

Authors
Category Primary study
JournalSwiss Med. Wkly
Year 2024
This article has no abstract
Epistemonikos ID: dec74a2c28145f106b1e023e88eac1082f1408ac
First added on: Nov 26, 2024